Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GSK Targets 85 Percent Of World’s Smokers With Cessation Products

This article was originally published in PharmAsia News

Executive Summary

GlaxoSmithKline plans a big marketing expansion in the emerging markets of the world, particularly in China and India. The firm is leading with its smoking-cessation drugs, targeting 20 new markets as it seeks to increase sales in the developing world. GSK markets lozenges and patches to help smokers quit, but has not been marketing them heavily outside of the developed world. Current statistics indicate that most of the world's smokers live in developing nations only now mounting anti-smoking campaigns. GSK plans to reach 85 percent of the smokers in the world within five years. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts